Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Chemical biology

How to minimalize antibodies

The success of antibodies as pharmaceuticals has triggered interest in crafting much smaller mimics. A crucial step forward has been taken with the chemical synthesis of small molecules that recruit immune cells to attack cancer cells.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Bridging target and effector cells.


  1. See all news & views


  1. Reichert, J. M. mAbs 7, 1–8 (2015).

    CAS  Article  Google Scholar 

  2. McEnaney, P. J. et al. J. Am. Chem. Soc. 136, 18034–18043 (2014).

    CAS  Article  Google Scholar 

  3. Rader, C. Trends Biotechnol. 32, 186–197 (2014).

    CAS  Article  Google Scholar 

  4. McEnaney, P. J., Parker, C. G., Zhang, A. X. & Spiegel, D. A. ACS Chem. Biol. 7, 1139–1151 (2012).

    CAS  Article  Google Scholar 

  5. Dennis, M. S. et al. J. Biol. Chem. 277, 35035–35043 (2002).

    CAS  Article  Google Scholar 

  6. Kodadek, T. Curr. Opin. Chem. Biol. 14, 713–720 (2010).

    CAS  Article  Google Scholar 

  7. Frankel, S. R. & Baeuerle, P. A. Curr. Opin. Chem. Biol. 17, 385–392 (2013).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Christoph Rader.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rader, C. How to minimalize antibodies. Nature 518, 38–39 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing